State of Alaska Department of Revenue Has $7.24 Million Stock Position in HCA Healthcare, Inc. (NYSE:HCA)

State of Alaska Department of Revenue lifted its position in HCA Healthcare, Inc. (NYSE:HCA) by 0.8% in the 1st quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 20,955 shares of the company’s stock after acquiring an additional 160 shares during the quarter. State of Alaska Department of Revenue’s holdings in HCA Healthcare were worth $7,241,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also modified their holdings of HCA. Norges Bank purchased a new stake in shares of HCA Healthcare in the fourth quarter worth approximately $840,286,000. GAMMA Investing LLC lifted its position in HCA Healthcare by 40,527.3% in the 1st quarter. GAMMA Investing LLC now owns 1,703,907 shares of the company’s stock worth $5,887,850,000 after buying an additional 1,699,713 shares in the last quarter. Royal London Asset Management Ltd. grew its holdings in shares of HCA Healthcare by 62.0% during the 4th quarter. Royal London Asset Management Ltd. now owns 1,500,786 shares of the company’s stock valued at $450,461,000 after acquiring an additional 574,239 shares in the last quarter. Barclays PLC boosted its position in HCA Healthcare by 85.7% during the fourth quarter. Barclays PLC now owns 1,061,891 shares of the company’s stock valued at $318,727,000 after purchasing an additional 489,916 shares during the last quarter. Finally, Two Sigma Investments LP increased its position in HCA Healthcare by 12,016.0% in the 4th quarter. Two Sigma Investments LP now owns 467,437 shares of the company’s stock worth $140,301,000 after purchasing an additional 463,579 shares during the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts recently commented on HCA shares. Guggenheim began coverage on HCA Healthcare in a report on Wednesday, April 9th. They issued a “neutral” rating on the stock. Morgan Stanley set a $410.00 price target on shares of HCA Healthcare and gave the company an “equal weight” rating in a report on Monday, June 9th. Robert W. Baird reissued a “neutral” rating and set a $336.00 target price (down from $396.00) on shares of HCA Healthcare in a research report on Tuesday, April 15th. Stephens upgraded HCA Healthcare to a “strong-buy” rating in a research note on Monday, June 2nd. Finally, Wells Fargo & Company upgraded HCA Healthcare from an “underweight” rating to an “equal weight” rating and boosted their target price for the stock from $320.00 to $385.00 in a report on Thursday, May 29th. Seven investment analysts have rated the stock with a hold rating, twelve have given a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat.com, HCA Healthcare currently has an average rating of “Moderate Buy” and an average target price of $392.47.

Insider Activity

In other news, COO Jon M. Foster sold 15,698 shares of the business’s stock in a transaction on Tuesday, May 13th. The shares were sold at an average price of $369.32, for a total value of $5,797,585.36. Following the sale, the chief operating officer now owns 12,646 shares in the company, valued at approximately $4,670,420.72. The trade was a 55.38% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 1.30% of the company’s stock.

HCA Healthcare Stock Performance

NYSE:HCA opened at $376.57 on Friday. The company has a debt-to-equity ratio of 69.07, a quick ratio of 1.06 and a current ratio of 1.19. The firm’s 50-day moving average is $361.42 and its 200-day moving average is $334.42. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $417.14. The company has a market cap of $90.59 billion, a price-to-earnings ratio of 16.74, a PEG ratio of 1.30 and a beta of 1.49.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Friday, April 25th. The company reported $6.45 EPS for the quarter, topping analysts’ consensus estimates of $5.75 by $0.70. The company had revenue of $18.32 billion during the quarter, compared to the consensus estimate of $18.26 billion. HCA Healthcare had a return on equity of 1,063.91% and a net margin of 8.07%. The company’s quarterly revenue was up 5.7% on a year-over-year basis. During the same quarter last year, the company earned $5.36 EPS. Equities research analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, June 30th. Investors of record on Monday, June 16th will be given a $0.72 dividend. This represents a $2.88 annualized dividend and a yield of 0.76%. The ex-dividend date of this dividend is Monday, June 16th. HCA Healthcare’s dividend payout ratio (DPR) is presently 12.81%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.